73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
How much sun can (and should) I get?

How much sun can (and should) I get?

by Katie Lee and Rachel Neale,The ConversationCredit: Unsplash/CC0 Public DomainAs we slide of out summer, you might be wondering how careful you need to be about sun exposure. Excessive exposur

How much sun can (and should) I get?

by Katie Lee and Rachel Neale,The ConversationCredit: Unsplash/CC0 Public DomainAs we slide of out summer, you might be wondering how careful you need to be about sun exposure. Excessive exposur
Prenatal exposure to anti-nausea drug in '60s, '70s tied to increased risk of colorectal cancer

Prenatal exposure to anti-nausea drug in '60s, '70s tied to increased risk of colorectal cancer

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPrenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase ri

Prenatal exposure to anti-nausea drug in '60s, '70s tied to increased risk of colorectal cancer

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPrenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase ri
Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta
The molecules behind metastasis

The molecules behind metastasis

by Greta Friar,Whitehead Institute for Biomedical ResearchBreast cancer stem cells (red) that have reached the lung begin to divide into clusters that could become metastatic tumors. Credit: Art

The molecules behind metastasis

by Greta Friar,Whitehead Institute for Biomedical ResearchBreast cancer stem cells (red) that have reached the lung begin to divide into clusters that could become metastatic tumors. Credit: Art
Novel late-stage colorectal cancer treatment proves effective in preclinical models

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre

Novel late-stage colorectal cancer treatment proves effective in preclinical models

by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre
Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening

Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening

by International Association for the Study of Lung CancerTop 10 global causes of deaths,2016. Credit:Journal of Thoracic Oncology(2023). DOI: 10.1016/j.jtho.2023.11.013Annual low-dos

Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening

by International Association for the Study of Lung CancerTop 10 global causes of deaths,2016. Credit:Journal of Thoracic Oncology(2023). DOI: 10.1016/j.jtho.2023.11.013Annual low-dos
Cancer metastasis: Tumor plasticity counts

Cancer metastasis: Tumor plasticity counts

by Université libre de BruxellesCredit: CC0 Public DomainCancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality. To under

Cancer metastasis: Tumor plasticity counts

by Université libre de BruxellesCredit: CC0 Public DomainCancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality. To under
Inhibiting the biological crosstalk of autophagy and mitochondrial function underlying pancreatic ductal adenocarcinoma

Inhibiting the biological crosstalk of autophagy and mitochondrial function underlying pancreatic ductal adenocarcinoma

by Thamarasee Jeewandara , Medical XpressAutophagy inhibition leads to a drop in the LIP in PDAC. (A) Autophagy was inhibited genetically or pharmacologically in PDAC cells, and the relative LIP was d

Inhibiting the biological crosstalk of autophagy and mitochondrial function underlying pancreatic ductal adenocarcinoma

by Thamarasee Jeewandara , Medical XpressAutophagy inhibition leads to a drop in the LIP in PDAC. (A) Autophagy was inhibited genetically or pharmacologically in PDAC cells, and the relative LIP was d
Tracking radiation treatment in real time promises safer, more effective cancer therapy

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi
Pembrolizumab shows survival benefit for patients with renal cancer

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,
Keeping aggressive cancer cells in check by blocking a protein responsible for repairs

Keeping aggressive cancer cells in check by blocking a protein responsible for repairs

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained

Keeping aggressive cancer cells in check by blocking a protein responsible for repairs

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained
Researchers propose a navigation system to tackle medication supply bottlenecks

Researchers propose a navigation system to tackle medication supply bottlenecks

by Christoph Elhardt,ETH ZurichWholesalers can ease supply bottlenecks by rerouting remainder stocks of medications in short supply. Credit: ETH ZurichSupply bottlenecks for medications present

Researchers propose a navigation system to tackle medication supply bottlenecks

by Christoph Elhardt,ETH ZurichWholesalers can ease supply bottlenecks by rerouting remainder stocks of medications in short supply. Credit: ETH ZurichSupply bottlenecks for medications present